Gemcitabine in patients with nonresectable cancer of the biliary system or advanced gallbladder cancer (CROSBI ID 507590)
Prilog sa skupa u zborniku | sažetak izlaganja sa skupa | međunarodna recenzija
Podaci o odgovornosti
Dobrila-Dintinjana, Renata ; Ružić, Alen ; Štimac, Davor ; Dintinjana, Marijan
engleski
Gemcitabine in patients with nonresectable cancer of the biliary system or advanced gallbladder cancer
The best supportive care in patients with nonresectable cancer of the biliary system or advanced a gallbladder cancer is not considered as sufficient. The aim of the study was to evaluate effectiveness of gemcitabine and cisplatine for patients with nonresectable cancer of the biliary system with advanced gallbladder cancer. Conclusion: The results indicate that the treatment of gallbladder cancer and nonresectable cancer of the biliary system with gemcitabine and cisplatin is effective , well tolerated and eeds to clinical benefit.
gallbladder cancer; gemcitabine
Rad je prezentiran i na skupu 10th UEGW : Poster Presentations, održanom 2002.g., Padova, Italija ; Knjiga sažetaka u: Gut 50 (2002) (S) ; str. 51-51.
nije evidentirano
nije evidentirano
nije evidentirano
nije evidentirano
nije evidentirano
Podaci o prilogu
311-311.
2002.
nije evidentirano
objavljeno
Podaci o matičnoj publikaciji
Abstracts of the 10th European Gastroenterology Week (EUGW) ; u: Gut 50 (2002) (S)
Classen, M
Georg Thieme Verlag
Podaci o skupu
European Gastroenterology Week (10 ; 2002)
poster
19.10.2002-23.10.2002
Ženeva, Švicarska